Health TrialsbyHealthPanel

Xanthohumol and Viral Infections (XL)

ConditionInfection Viral
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Vienna

About this trial

The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

healthy

BMI >18 kg/m² or < 28kg/m²

Disqualifiers

food intolerances

food allergies

chronic inflammatory diseases

metabolic diseases

Trial design

Design model

Parallel

Treatments tested in this trial

  • Xanthohumol

    Dietary supplement

    Participants consume twice per day a study drink which contains 0,75 mg soluble Xanthohumol for 90 days

  • Placebo

    Dietary supplement

    Participants consume twice per day a study drink which contains 0 mg soluble Xanthohumol for 90 days

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: PlaceboExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Changes in severity and duration of viral infections

Changes in score of Wisconsin Upper Respiratory Symptom Survey

Time frame
90 days

Secondary outcomes

1

Changes in blood lipid levels

Changes in triglyceride levels (mg/dl) and cholesterol levels (mg/dl)

Time frame
90 days
2

Changes in cognitive skills

Assessment of cognitive processes using stroop test

Time frame
90 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Vienna

Lead sponsor

Source ClinicalTrials.gov
Apply now